Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ANG Lifesciences India Ltd has informed BSE that the trading window for its securities will remain closed for insiders, designated persons, and their immediate relatives starting 1 July 2025. The closure will stay in effect until 48 hours after the company declares its unaudited standalone and consolidated financial results for the quarter ended 30 June 2025 (Q1 FY26). The date of the board meeting to consider these quarterly results will be announced separately. This is a routine compliance intimation under SEBI's Insider Trading Regulations, 2015.
No direct impact on shareholders or stock price. It is a standard regulatory communication preventing insider trading ahead of quarterly results; investors should expect results to be announced in the coming weeks.